Sanofi (SNYNF) Cash from Investing Activities (2009 - 2026)

Sanofi has disclosed Cash from Investing Activities across 8 years of filings, most recently posting -$2.7 billion for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$2.7 billion, down 226.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.9 billion (up 152.93% YoY), and the FY2025 annual result was -$2.8 billion, up 39.52% from the prior year.
• Cash from Investing Activities came in at -$2.7 billion for Q1 2026 at Sanofi, up from -$2.8 billion in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $10.8 billion in Q2 2025 to a low of -$4.7 billion in Q4 2024.
• The 3-year median for Cash from Investing Activities is -$1.7 billion (2025), against an average of -$541.5 million.
• Across the five-year window, Cash from Investing Activities jumped 428.48% in 2025 and sank 226.73% in 2026, its largest moves.
• Sanofi's Cash from Investing Activities stood at -$4.7 billion in 2024, then surged by 39.52% to -$2.8 billion in 2025, then increased by 6.37% to -$2.7 billion in 2026.
• The last three Cash from Investing Activities figures came in at -$2.7 billion (Q1 2026), -$2.8 billion (Q4 2025), and -$369.4 million (Q3 2025), per Business Quant data.